The Commercial Director, Obesity at Numan owns the obesity business end-to-end: the proposition, the P&L and the commercial outcomes. If obesity grows profitably, it’s because you made the right calls.
If it doesn’t, you’ll know why. You’ll lead cross‑functional teams across marketing, CRM, product, pricing and clinical ops to drive growth, manage key partnerships (Novo Nordisk and Eli Lilly) at UK leadership level, and ensure decisions stay within clinical guardrails while using AI for
#J-18808-Ljbffr…
